No, all clinical experience is accepted. However, it is an advantage
if you have knowledge within endocrinology, cardiology,
gastroenterology, hepatology, neurology, biomarker development, gene
therapy, among others.
Yes. Working with the medical tasks in global development, global
safety and global medical affairs you will use your clinical knowledge.
Yes, being a medical doctor is a prerequisite. The programme is
designed specifically for medical doctors with no prior industry experience.
In order to qualify for the Pharmaceutical Medicine Programme, you
must hold a university degree as a medical doctor. You should have
passed postgraduate internship and possess 2-5 years of documented
scientific and/or clinical experience. You must have practical and
analytical skills and be capable of working independently, while at
the same time accepting a strong team focus and influence. Moreover,
you should be prepared and willing to travel and work in an
international arena. We expect that you are results oriented, good at
setting priorities and have a strong personal impact and drive.
Lastly, we expect you to have excellent English skills and a high
proficiency in IT knowledge.
Yes, Novo Nordisk is a global company and welcomes applications from
all over the world. It is not a prerequisite that you understand
and/or can speak Danish but you must be fluent in English (written and verbal).
The departments included in the programme are all situated at
headquarters. That means that you will be working within the
Copenhagen area during the 2 years of the Pharmaceutical Medicine
Programme. Expatriation is not a part of the programme. After the
successful completion of the programme each PMP doctor will be offered
a permanent position within headquarters (Denmark). If it is a wish
from the PMP doctor and availability enables it, a position in one of
Novo Nordisk’s affiliates around the world may be offered.
This would over-qualify the applicant and is neither the scope nor
profile we are looking for with this programme. The purpose of the
programme is to introduce a medical doctor to the pharma industry and
all the facets relevant for a medical doctor working in Novo Nordisk
We are looking for around five MDs every year. You are welcome to
apply throughout the month of February through the application link at
the homepage. The programme starts in September the same year.
Work with your competencies within clinical work, scientific
research, clinical drug research and business/economy.
The salary is at a competitive level compared to the pharmaceutical
industry. It is equal to that of a young medical doctor in an entry
level position within the pharmaceutical industry. Along with the
salary come additional benefits, for example an annual bonus,
computer, mobile phone, re-location aid and an extensive and generous
training course budget.
The two-year programme consists of three eight-month rotations in
three different areas of the organisation - Clinical Drug Development,
Global Medical Affairs and Global Safety. Within the three departments
you will be involved in specific everyday tasks through which you will
get experience with elements such as clinical development planning of
a drug candidate, global and local positioning strategies for a
marketed drug, medical documentation in a new drug application,
pharmacovigilance activities such as monitoring adverse events in
clinical trials for developmental drugs and making surveys of adverse
events for marketed drugs. In addition to the rotations, an individual
course plan is created allowing the candidates to participate in
internal and external courses. This can for example include training
in GCP (good clinical practice), biostatistics, computer skills and
participation in congresses.
Yes, it is a permanent position. It is not a scholarship or a grant.
The programme is structured around three main activities within the
development of new drugs, where strong medical skills are highly needed.
Global Development, where trial protocols and development
plans for new potential drug candidates are made and communication
with the authorities concerning approval of trials and drugs is
Global Medical Affairs, where input is given to
the clinical development plans and product strategies. Publication
planning, medical communication and data presentation are also
anchored in the Medical Affairs rotation.
where adverse events are assessed, safety reports are submitted to
competent authorities and trial protocols are reviewed.
After/upon successful completion of the programme you will be offered
a position usually within one of the three departments in the
programme. Your final position depends on your wishes, feedback from
managers and vacancies in the respective departments.